DGE invites life science Diversity, Equity & Inclusion (“DEI”) practitioners, health equity advocates, HR executives, and health policy leaders, to attend the 3rd Advancing Diversity, Equity & Inclusion in Pharma & Healthcare Summit to be held at the Hyatt Bellevue, Philadelphia, PA, on September 19-20, 2023. The industry’s leading event will focus on putting developing policies into practices including novel case studies and sessions on important areas.
The leading DEI event for Pharma & Healthcare serves as a dynamic platform for industry leaders, advocates, practitioners and influencers to convene, work toward common goals and drive the life science ecosystem toward positive change. Attendees will get the unique opportunity to meet with like-minded professionals, benchmark with peers and engage in thought-provoking discussions in the pursuit of an equitable and more inclusive future for all.
Featuring an exceptional blend of collaborative sessions, insightful presentations, and actionable strategies, this groundbreaking summit will leave an unforgettable mark on participants. They will engage in valuable panel discussions and gain information from keynote speakers who will share their unique strategies and experiences.
Advancing Diversity, Equity, and Inclusion
The summit will focus on the growing prominence of diversity and inclusion in clinical research and drug development. Expert-led sessions will explore the diverse patient populations in clinical trials while addressing differences in healthcare results.
Attendees will gain valuable insights into the challenges faced in implementing an effective DEI practice from the ground up as well as gathering cross-functional insights on DEI collaboration and the role of medical communications to address health inequities and disparities. In addition, the agenda will cover integrating DEI into talent recruitment, transforming organizational culture and utilizing change management. The event will also offer new case studies from Pfizer, Merck, Sanofi, Takeda and others. Formats will also include panel discussions such as the power of mentorship and ERGs.
The agenda will delve into the importance of actionable workplace culture that supports equity and inclusivity at all levels. The professionals from the pharma and healthcare industries will bring together different perspectives and strategies for improving DEI in the workplace as well as throughout the entire life science ecosystem most importantly with patients. The main focus will be to create industry-wide best practices and solutions that drive meaningful change throughout the industry that is viewed as a leader in diversity, equity and inclusion.
To learn more, please visit https://ibn.fm/S7hSF.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]